Page contents Full notification Final report General information GMO characterization European Commission administrative Information Return to search

Full notification Final report - General information Notification Number B/NL/23/008 Member State to which the notification was sent Netherlands Date of acknowledgement from the Member State Competent Authority 21/06/2023 Title of the Project Lentiviral or retroviral transduced human cells to prevent or treat disease Proposed period of release: 01/07/2023 to 30/06/2033 Name of the Institute(s) or Company(ies) Princess Maxima Center for Pediatric Oncology
Is the same GMO been notified elsewhere by the same notifier? No Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: Other Identity of the GMO: Human cells (macrophages and macrophage-like cells excluded) transduced with lentiviral or retroviral particles that express a non-harmful protein Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Genus: Homo Species: Homo Sapiens Subspecies: Human Strain: N/A Pathovar: N/A European Commission administrative Information Consent given by the Member State Competent Authority: Yes
08/07/2023